82 related articles for article (PubMed ID: 2056386)
21. [A comparative study of DNA measurement of bladder cancer from image cytometry and chromosome aberration in in situ hybridization].
Nemoto R; Nakamura I; Uchida K; Harada M
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():153-7. PubMed ID: 7611780
[TBL] [Abstract][Full Text] [Related]
22. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
23. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
[TBL] [Abstract][Full Text] [Related]
24. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
25. Interphase cytogenetics and flow cytometry analyses of renal tumours.
Grollino MG; Cavallo D; Di Silverio F; Rocchi M; De Vita R
Anticancer Res; 1993; 13(6A):2239-44. PubMed ID: 8297139
[TBL] [Abstract][Full Text] [Related]
26. Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes.
Cajulis RS; Frias-Hidvegi D
Acta Cytol; 1993; 37(3):391-6. PubMed ID: 8388611
[TBL] [Abstract][Full Text] [Related]
27. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
28. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
[TBL] [Abstract][Full Text] [Related]
29. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
Shou J; Wang M; Ma J
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic methods in the diagnosis of invasive bladder cancer.
Krause FS; Feil G; Zumbrägel A; Bichler KH
Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy.
Mengual L; Marín-Aguilera M; Ribal MJ; Burset M; Villavicencio H; Oliver A; Alcaraz A
Eur Urol; 2007 Sep; 52(3):752-9. PubMed ID: 17379395
[TBL] [Abstract][Full Text] [Related]
32. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
[TBL] [Abstract][Full Text] [Related]
33. Detection of genetic aberrations in bladder cancer using in situ hybridization.
Ramaekers FC; Hopman AH
Ann N Y Acad Sci; 1993 Mar; 677():199-213. PubMed ID: 8098592
[No Abstract] [Full Text] [Related]
34. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
Miyakawa A; Tachibana M; Tazaki H
Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
[TBL] [Abstract][Full Text] [Related]
36. [Demonstration of gene amplification in urinary bladder cancer by fluorescent in situ hybridization (FISH)].
Sauter G; Moch H; Gudat F; Mihatsch MJ; Haley J; Meecker T; Waldman F
Verh Dtsch Ges Pathol; 1993; 77():247-51. PubMed ID: 7511290
[TBL] [Abstract][Full Text] [Related]
37. Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer.
Mahdy E; Yoshihiro S; Zech L; Wester K; Pan Y; Busch C; Döhner H; Kallioniemi O; Bergerheim U; Malmström PU
Anticancer Res; 1999; 19(1A):7-12. PubMed ID: 10226518
[TBL] [Abstract][Full Text] [Related]
38. [Application of simultaneous flow cytometric bromodeoxyuridine (BrdU)/DNA analysis. 1. Basic and technical studies].
Shimabukuro T
Hinyokika Kiyo; 1988 Aug; 34(8):1339-48. PubMed ID: 3057828
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
Webster L; Hodgkiss RJ; Wilson GD
Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
[TBL] [Abstract][Full Text] [Related]
40. Numerical aberrations of chromosomes 1 and 7 in renal cell carcinomas as detected by interphase cytogenetics.
Beck JL; Hopman AH; Feitz WF; Schalken J; Schaafsma HE; Van de Kaa CA; Ramaekers FC; Hanselaar AG; De Wilde PC
J Pathol; 1995 Jun; 176(2):123-35. PubMed ID: 7636622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
